c-fos antisense reduces expression of Krox 24 in rat caudate and neocortex M. DragunowC. TseP. Lawlor OriginalPaper Pages: 395 - 405
Depletion of catalytic and regulatory subunits of protein kinase CK2 by antisense oligonucleotide treatment of neuroblastoma cells Luis UlloaJavier Díaz-NidoJesus Avila OriginalPaper Pages: 407 - 414
c-fos expression in the amygdala:In vivo antisense modulation and role in anxiety Christian MöllerOla BingMarkus Heilig OriginalPaper Pages: 415 - 423
Modulation of the PC12 cell response to nerve growth factor by antisense oligonucleotide to amyloid precursor protein Ronald E. MajochaSudhir AgrawalCharles A. Marotta OriginalPaper Pages: 425 - 437
Antisense inhibition of low-affinity nerve growth factor receptor in kidney cultures: Power and pitfalls K. SainioM. SaarmaH. Sariola OriginalPaper Pages: 439 - 457
Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors Deborah PatinkinEfrat Lev-LehmanHermona Soreq OriginalPaper Pages: 459 - 473
Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-Labeled antisense oligodeoxynucleotides in the rat Frances YeeHans EricsonClaes Wahlestedt OriginalPaper Pages: 475 - 486
The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptationsin vivo Karl-Hermann SchlingensiepenFranziska WollnikWolfgang Brysch OriginalPaper Pages: 487 - 505
The application of antisense oligonucleotide technology to the brain: Some pitfalls B. J. ChiassonJ. N. ArmstrongH. A. Robertson OriginalPaper Pages: 507 - 521
Inhibition of gene expression with ribozymes Peter MarschallJames B. ThomsonFritz Eckstein OriginalPaper Pages: 523 - 538
Study of stimulus-secretion coupling in single cells using antisense oligodeoxynucleotides and patch-clamp techniques to inhibit specific protein expression Pierre-Marie LledoWilliam T. MasonRobert Zorec OriginalPaper Pages: 539 - 556
Design and application of antisense oligonucleotides in cell culture,in vivo, and as therapeutic agents Wolfgang BryschKarl-Hermann Schlingensiepen Contemporary Techniques Pages: 557 - 568
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration Marina PizziAlessandra ValerioMaurizio Memo Contemporary Techniques Pages: 569 - 578
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats Thomas SkutellaAlexandra MontkowskiGustav F. Jirikowski Contemporary Techniques Pages: 579 - 588